Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Susanne Hultsch
Observed names:
Hultsch, Susanne,
S. Hultsch
Observed institutions:
University of Helsinki,
Breast International Group,
Institute for Molecular Medicine Finland,
HiLIFE – Elämäntieteiden Instituutti
ORCID:
0000-0001-6739-1665
Observed ORCID:
0000-0001-6739-1665
OpenAlex ID:
A5085642802
Association of tamoxifen resistance and lipid reprogramming in breast cancer
2018
·
Susanne Hultsch
, Matti Kankainen
, et al.
·
BMC Cancer
·
193
PDF
Reanalysis of RNA-Sequencing Data Reveals Several Additional Fusion Genes with Multiple Isoforms
2012
·
Sara Kangaspeska
, Susanne Hultsch
, et al.
·
PLoS ONE
·
85
PDF
Association of tamoxifen resistance and lipid reprogramming in breast cancer
2018
·
Susanne Hultsch
, Matti Kankainen
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
25
PDF
STAT3 activation in HER2 ‐positive breast cancers: Analysis of data from a large prospective trial
2020
·
Amir Sonnenblick
, Dominique Agbor‐tarh
, et al.
·
International Journal of Cancer
·
19
PDF
Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer
2016
·
Sara Kangaspeska
, Susanne Hultsch
, et al.
·
BMC Cancer
·
14
PDF
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy—a sub-analysis of the ALTTO study
2022
·
Guilherme Nader-Marta
, Véronique Debien
, et al.
·
British Journal of Cancer
·
2
Rethinking Trust in Synthetic Health Data: Lessons From 7 European Research Initiatives
2026
·
Jens Declerck
, Dipak Kalra
, et al.
·
Journal of Medical Internet Research
·
1
Seven shades of tamoxifen resistance : Molecular mechanisms of drug resistance in breast cancer
2018
·
Hultsch, Susanne
·
Työväentutkimus Vuosikirja
·
1
PDF
Abstract 2935: Systematic drug testing and RNA-sequencing of tamoxifen resistant breast cancer cell lines
2016
·
Susanne Hultsch
, Sara Kangaspeska
, et al.
·
Cancer Research
·
1
221P Long-term outcomes of patients with node-negative, ≤3cm, HER2+ breast cancer (BC) enrolled in ALTTO
2020
·
D. Eiger
, Z. Tsourti
, et al.
·
Annals of Oncology
Additional file 6: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
2018
·
Hultsch, Susanne
, Kankainen, Matti
, et al.
·
Figshare
Additional file 4: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
2018
·
Hultsch, Susanne
, Kankainen, Matti
, et al.
·
Figshare
Additional file 3: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
2018
·
Hultsch, Susanne
, Kankainen, Matti
, et al.
·
Figshare
Additional file 2: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
2018
·
Hultsch, Susanne
, Kankainen, Matti
, et al.
·
Figshare
Additional file 7: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
2018
·
Hultsch, Susanne
, Kankainen, Matti
, et al.
·
Figshare
Additional file 8: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
2018
·
Hultsch, Susanne
, Kankainen, Matti
, et al.
·
Figshare
Additional file 1: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
2018
·
Hultsch, Susanne
, Kankainen, Matti
, et al.
·
Figshare
Additional file 9: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
2018
·
Hultsch, Susanne
, Kankainen, Matti
, et al.
·
Figshare
Additional file 10: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
2018
·
Hultsch, Susanne
, Kankainen, Matti
, et al.
·
Figshare
Additional file 10: of Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer
2016
·
Kangaspeska, Sara
, Hultsch, Susanne
, et al.
·
Figshare
Additional file 6: of Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer
2016
·
Kangaspeska, Sara
, Hultsch, Susanne
, et al.
·
Figshare
Additional file 9: of Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer
2016
·
Kangaspeska, Sara
, Hultsch, Susanne
, et al.
·
Figshare
Additional file 7: of Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer
2016
·
Kangaspeska, Sara
, Hultsch, Susanne
, et al.
·
Figshare
Additional file 1: of Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer
2016
·
Kangaspeska, Sara
, Hultsch, Susanne
, et al.
·
Figshare
Additional file 5: of Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer
2016
·
Kangaspeska, Sara
, Hultsch, Susanne
, et al.
·
Figshare
Show more works
View as search
Works count:
42
Citation count:
341
H-index:
5
I10-index:
5
Year
Topic
Type
